Diabetes Type 2 clinical trials at UC Irvine

4 in progress, 2 open to eligible people

Showing trials for

  • Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

    open to eligible people ages 55 years and up

    TRANSFORM is a prospective, randomized, open blinded endpoint (PROBE), event-driven, pragmatic trial in patients who are at increased risk for atherosclerotic cardiovascular (CV) disease but with no known symptomatic CV disease. The trial tests the hypothesis that a Cleerly Coronary Artery Disease (CAD) Staging System-based care strategy reduces CV events compared with risk factor-based care.

    Orange, California and other locations

  • HOPE Intervention for Fitness

    open to eligible people ages 18 years and up

    We will test the HOPE intervention on changing behavior of people to exercise more (take more steps each day).

    Irvine, California

  • Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

    Sorry, in progress, not accepting new patients

    The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.

    Orange, California and other locations

  • AT-001 in Patients With Diabetic Cardiomyopathy

    Sorry, in progress, not accepting new patients

    This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic Cardiomyopathy at high risk of progression to overt heart failure.

    Orange, California and other locations

Our lead scientists for Diabetes Type 2 research studies include .

Last updated: